RedHill Biopharma (RDHL) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
RedHill Biopharma Ltd. has announced its annual general meeting scheduled for September 17, 2024, where shareholders will vote on critical matters such as the appointment of auditors, re-election of board members, and approval of restricted share units for directors and executives. The company emphasizes the importance of shareholder votes, urging ADS holders to submit their proxies ahead of the meeting to ensure their shares are represented. All relevant materials and proposed resolutions will be accessible on the company’s and the SEC’s websites.
For further insights into RDHL stock, check out TipRanks’ Stock Analysis page.